Global Oligosaccharide for Infant Formula Market Growth 2023-2029

Global Oligosaccharide for Infant Formula Market Growth 2023-2029

The global Oligosaccharide for Infant Formula market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Human breast milk contains a variety of oligosaccharides that play important roles in promoting the growth of beneficial bacteria in the baby's gut and supporting overall gut health. However, these oligosaccharides are not present in standard cow's milk-based infant formulas. To bridge this gap, oligosaccharides derived from either human milk or other sources, such as plants, are added to infant formula.

The most commonly used oligosaccharides in infant formula include galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS). These oligosaccharides are structurally similar to the ones found in human breast milk and serve as a food source for beneficial bacteria (probiotics) in the baby's gut. By promoting the growth of these beneficial bacteria, oligosaccharides help establish a healthy gut microbiota and support various aspects of infant health and development.

Adding oligosaccharides to infant formula offers several potential benefits. They can contribute to the development of a balanced and diverse gut microbiome, which may support the baby's immune system, aid in digestion, and potentially reduce the risk of certain health conditions, such as allergies and infections. Additionally, oligosaccharides in infant formula may have prebiotic effects, which means they selectively stimulate the growth and activity of beneficial bacteria while inhibiting the growth of harmful bacteria.

It's important to note that oligosaccharides in infant formula should not be confused with prebiotics or probiotics. While oligosaccharides serve as prebiotics, providing nourishment for probiotics, probiotics themselves are live bacteria or yeasts that can provide direct health benefits when consumed.

Human breast milk contains a variety of oligosaccharides that play important roles in promoting the growth of beneficial bacteria in the baby's gut and supporting overall gut health. However, these oligosaccharides are not present in standard cow's milk-based infant formulas. To bridge this gap, oligosaccharides derived from either human milk or other sources, such as plants, are added to infant formula.

The most commonly used oligosaccharides in infant formula include galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS). These oligosaccharides are structurally similar to the ones found in human breast milk and serve as a food source for beneficial bacteria (probiotics) in the baby's gut. By promoting the growth of these beneficial bacteria, oligosaccharides help establish a healthy gut microbiota and support various aspects of infant health and development.

Adding oligosaccharides to infant formula offers several potential benefits. They can contribute to the development of a balanced and diverse gut microbiome, which may support the baby's immune system, aid in digestion, and potentially reduce the risk of certain health conditions, such as allergies and infections. Additionally, oligosaccharides in infant formula may have prebiotic effects, which means they selectively stimulate the growth and activity of beneficial bacteria while inhibiting the growth of harmful bacteria.

It's important to note that oligosaccharides in infant formula should not be confused with prebiotics or probiotics. While oligosaccharides serve as prebiotics, providing nourishment for probiotics, probiotics themselves are live bacteria or yeasts that can provide direct health benefits when consumed.



Oligosaccharides for infant formula refer to a group of carbohydrates that are added to infant formula to mimic the naturally occurring oligosaccharides found in human breast milk. Oligosaccharides are composed of a small number of sugar molecules linked together, typically ranging from two to ten sugar units.

LPI (LP Information)' newest research report, the “Oligosaccharide for Infant Formula Industry Forecast” looks at past sales and reviews total world Oligosaccharide for Infant Formula sales in 2022, providing a comprehensive analysis by region and market sector of projected Oligosaccharide for Infant Formula sales for 2023 through 2029. With Oligosaccharide for Infant Formula sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligosaccharide for Infant Formula industry.

This Insight Report provides a comprehensive analysis of the global Oligosaccharide for Infant Formula landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligosaccharide for Infant Formula portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oligosaccharide for Infant Formula market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligosaccharide for Infant Formula and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligosaccharide for Infant Formula.

This report presents a comprehensive overview, market shares, and growth opportunities of Oligosaccharide for Infant Formula market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Fructooligosaccharide
Galactooligosaccharides
Human Milk Oligosaccharides

Segmentation by application
Standard
Follow on
Toddler
Specialty

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
FrieslandCampina
Meiji
Yakult
Baolingbao
Beneo-Orafti
Bailong
Ingredion
Sensus
QHT
Nikon Shikuhin KaKo
Nissin-sugar
Cosucra

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oligosaccharide for Infant Formula market?

What factors are driving Oligosaccharide for Infant Formula market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oligosaccharide for Infant Formula market opportunities vary by end market size?

How does Oligosaccharide for Infant Formula break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.